News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News Registry Data Reassure on Safety With Next-Generation Watchman Device L.A. McKeown July 30, 2024
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women L.A. McKeown November 21, 2022
News Conference News ACC 2022 Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough Michael O'Riordan April 04, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Even Less-Severe COVID-19 Can Have Long-term CV Effects Caitlin E. Cox February 10, 2022
News Conference News AHA 2021 Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND Michael O'Riordan November 17, 2021
News Daily News Uptick in ‘Implausible’ Cancers Reported After ARB Recalls L.A. McKeown August 20, 2021
News Daily News Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk Michael O'Riordan March 23, 2021
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Daily News CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers Michael O'Riordan March 27, 2019
News Daily News Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients Michael O'Riordan January 17, 2017
News Daily News Decline Seen in Readmissions After PCI in the Medicare Population Todd Neale July 21, 2016
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015